Riskpilot← Back to searchSign inGet full accessCecilia Stokkeland AB
ABIn liquidationOrg 5569890493Hospital activities · NACE 8610Est. 20141 employees
Revenue 2023
SEK 47K
-93% vs 2022
EBITDA margin
-186.7%
-66% vs 2022
Equity ratio
91.5%
Financial strength
Net profit 2023
SEK -84K
-59% vs 2022
| Revenue | SEK 47K | -93% |
| EBITDA | SEK -88K | -66% |
| Net profit | SEK -84K | -59% |
| Total assets | SEK 372K | -24% |
| Equity | SEK 340K | -20% |
| Employees | 1 | — |
Legal name
Cecilia Stokkeland AB
Org number
5569890493
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
4 november 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn Firman tecknas var för sig av externa firmatecknarna
Company purpose
Tillhandahålla specialistläkare inom anestesi och intensivvård för inom sjukvården sedvanligt förekommande arbetsuppgifter samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 868 | 1 078 | 1 130 | 642 | 47 |
| Staff expenses | — | — | — | −607 | −80 |
| EBITDA | 224 | 213 | 246 | −53 | −88 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 224 | 213 | 246 | −53 | −88 |
| Net financials | — | — | 1 | 1 | 5 |
| Profit before tax | 224 | 214 | 247 | −53 | −84 |
| Tax | −33 | −46 | −53 | — | — |
| Net profit | 191 | 168 | 194 | −53 | −84 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 350 | 606 | 631 | 490 | 372 |
| Equity | 265 | 433 | 476 | 424 | 340 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 86 | 173 | 155 | 66 | 32 |
| Total debt | 86 | 173 | 155 | 66 | 32 |
EBITDA margin
-186.7%
This company
15.8%
Market median
-1282% vs market
20192023
Equity ratio
91.5%
This company
38.2%
Market median
+140% vs market
20192023
Return on equity
-24.6%
This company
18.4%
Market median
-234% vs market
20192023
Net profit margin
-177.1%
This company
8.1%
Market median
-2286% vs market
20192023
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20192023
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MV External Signatory | External Signatory | 2023 |
AB External Signatory | External Signatory | 2023 |
AE Liquidator | Liquidator | 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cecilia Stokkeland AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Veronica Vesterberg | External Signatory | 0 companies |
| Anna Birgitta Emanuelsson | External Signatory | 0 companies |
| Anna Elisabeth Adolfsson | Liquidator | 0 companies |
| Ann Cecilia Margareta Stokkeland | Board of Directors | 0 companies |
| Knut Stokkeland | Deputy Board Member | 0 companies |